Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study
CHU St Pierre Brussels HIV Cohort, Austrian HIV Cohort Study, Australian HIV Observational Database, AIDS Therapy Evaluation in the Netherlands National Observational HIV cohort, EuroSIDA cohort, Frankfurt HIV Cohort Study, Georgian National AIDS Health Information System, Nice HIV Cohort, ICONA Foundation, Modena HIV Cohort, PISCIS Cohort Study, Swiss HIV Cohort Study, Swedish InfCare HIV Cohort, Royal Free HIV Cohort Study, San Raffaele Scientific Institute, University Hospital Bonn HIV Cohort, University of Cologne HIV Cohort, Brighton HIV Cohort, and the National Croatian HIV cohort, ViiV Healthcare, Merck Life Sciences, Gilead Sciences, and the Centre of Excellence for Health, Immunity Infections (CHIP).
Authors
- Lene Ryom (ORCID: https://orcid.org/0000-0002-6436-6461)
- Joan Tallada (ORCID: https://orcid.org/0000-0002-7655-9068)
- Justyna Dominika Kowalska (ORCID: https://orcid.org/0000-0003-1166-4462)
- Jörg Janne Vehreschild (ORCID: https://orcid.org/0000-0002-5446-7170)
- Olaf Degen (ORCID: https://orcid.org/0000-0002-8315-6689)
- Antonella Castagna (ORCID: https://orcid.org/0000-0002-8338-9714)
- Josip Begovać (ORCID: https://orcid.org/0000-0003-2641-4327)
- Robert Zangerle (ORCID: https://orcid.org/0000-0002-5375-7299)
- Elmar Wallner
- Huldrych F. Günthard (ORCID: https://orcid.org/0000-0002-1142-6723)
- Erich S. Tusch (ORCID: https://orcid.org/0000-0003-1434-101X)
- Charlotte Martin (ORCID: https://orcid.org/0000-0002-8995-6230)
- Joanne Reekie (ORCID: https://orcid.org/0000-0001-8529-3559)
- Nadine Jaschinski (ORCID: https://orcid.org/0000-0003-4847-2966)
- Jens Dilling Lundgren (ORCID: https://orcid.org/0000-0001-8901-7850)
- Katharina Kusejko (ORCID: https://orcid.org/0000-0002-4638-1940)
- Cristina Mussini (ORCID: https://orcid.org/0000-0002-6615-4198)
- Christian Hoffmann (ORCID: https://orcid.org/0000-0002-1082-8093)
- Ferdinand W.N.M. Wit (ORCID: https://orcid.org/0000-0003-2066-8115)
- Vani Vannappagari
- Lars Peters
- Sofia Dos Santos Mendes
- Jim Rooney
Institutions
- Goethe University Frankfurt (DE)
- University of Modena and Reggio Emilia (IT)
- University of Copenhagen (DK)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Université Libre de Bruxelles (BE)
- University Hospital Centre Zagreb (HR)
- Vita-Salute San Raffaele University (IT)
- Universität Hamburg (DE)
- University of Milan (IT)
- University of Zurich (CH)
- Medical University of Warsaw (PL)
- Hvidovre Hospital (DK)
- Rigshospitalet (DK)
- Hochschule für Angewandte Wissenschaften Kiel (DE)
- University Hospital of Zurich (CH)
- University Medical Center Hamburg-Eppendorf (DE)
- University Hospital Schleswig-Holstein (DE)
- German Center for Infection Research (DE)
- Infektionsmedizinisches Centrum Hamburg (DE)
- Stichting HIV Monitoring (NL)
- European Organisation for Research and Treatment of Cancer (BE)
- Gilead Sciences (United States) (US)
- University Hospital Cologne (DE)
- Centre Hospitalier Universitaire de Saint-Pierre (BE)
- Medical University of Vienna (AT)
- University of Lübeck (DE)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.eclinm.2025.103521
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Gilead Sciences
- ViiV Healthcare